var data={"title":"Leukoencephalopathy due to heroin inhalation (chasing the dragon)","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Leukoencephalopathy due to heroin inhalation (chasing the dragon)</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/contributors\" class=\"contributor contributor_credentials\">Amy T Waldman, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/contributors\" class=\"contributor contributor_credentials\">Francisco Gonz&aacute;lez-Scarano, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/contributors\" class=\"contributor contributor_credentials\">John F Dashe, MD, PhD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jul 28, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION AND TERMINOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although heroin use by inhalation (&quot;chasing the dragon&quot;) first developed in the 1950s [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/1\" class=\"abstract_t\">1</a>], the leukoencephalopathy and neurologic symptoms associated with this method of heroin abuse were initially described in 1982 in a report from the Netherlands [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/2\" class=\"abstract_t\">2</a>].</p><p>&quot;Chasing the dragon&quot; is a method of heroin vapor inhalation that is distinct from smoking or sniffing heroin [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/1,3\" class=\"abstract_t\">1,3</a>]. Other names for this process include &quot;chinesing&quot; and &quot;Chinese blowing.&quot; A small amount of heroin powder is placed on aluminum foil, which is heated by placing a match or lighter underneath. The white powder becomes a reddish-brown gelatinous substance that releases a thick, white smoke, which resembles a dragon's tail. The fumes are &quot;chased&quot; or inhaled through a straw or small tube [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/4\" class=\"abstract_t\">4</a>].</p><p>This topic will discuss the pathogenesis, clinical features, diagnosis, and management of heroin leukoencephalopathy from chasing the dragon.</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The mechanism of neurologic injury related to heroin inhalation is unknown. Since heroin leukoencephalopathy has not been observed in users who inject or snort heroin, it is possible that unknown toxins contained in the heroin pyrolysate (the product of chemical change caused by heating) are responsible for the condition [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3\" class=\"abstract_t\">3</a>]. However, the disease was not replicated in rats exposed to this compound [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/2\" class=\"abstract_t\">2</a>]. Triethyl tin (TET), a component of inorganic tin, was also suspected since TET poisoning results in vacuolar white matter edema [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3,5\" class=\"abstract_t\">3,5</a>], but an etiologic role for TET is unlikely, since the TET content in aluminum foil is negligible [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3\" class=\"abstract_t\">3</a>].</p><p>Mitochondrial dysfunction may play a role in the development of heroin leukoencephalopathy, as suggested by mitochondrial changes on specimens from brain biopsy [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/2\" class=\"abstract_t\">2</a>], by elevated lactate on magnetic resonance spectroscopy [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3\" class=\"abstract_t\">3</a>], and by the clinical improvement with antioxidant therapy that has been reported in a few patients [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3\" class=\"abstract_t\">3</a>]. (See <a href=\"#H12\" class=\"local\">'Treatment'</a> below.)</p><p>In this syndrome, parkinsonian symptoms may be caused by reversible inhibition of tetrahydrobiopterin metabolism; tetrahydrobiopterin is required for the conversion of tyrosine to levodopa, the precursor of <a href=\"topic.htm?path=dopamine-drug-information\" class=\"drug drug_general\">dopamine</a>, and for the conversion of tryptophan to serotonin [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/6\" class=\"abstract_t\">6</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Despite the prevalence of heroin abuse, fewer than 100 cases had been reported by the year 2000 [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/7\" class=\"abstract_t\">7</a>]. An additional 27 cases were identified in British Columbia, Canada between 2001 and 2006 [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/8\" class=\"abstract_t\">8</a>].</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h1\">CLINICAL FEATURES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the initial cohort of 47 heroin vapor inhalers from the Netherlands, which remains the largest report in the literature, the leukoencephalopathy occurred in three stages [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/2\" class=\"abstract_t\">2</a>]. In the first stage, the initial symptoms (in order of decreasing frequency) were:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><span class=\"nowrap\">Soft/pseudobulbar</span> speech</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cerebellar ataxia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Motor restlessness</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><span class=\"nowrap\">Apathy/abulia/bradyphrenia</span></p><p/><p>After two to four weeks, approximately half of the patients progressed to the second (intermediate) stage, which was characterized by rapid worsening of cerebellar symptoms and additional features [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/2\" class=\"abstract_t\">2</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pyramidal tract signs</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hyperactive reflexes</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Spastic hemiplegia or quadriplegia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tremor and myoclonus</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chorea and athetosis</p><p/><p>A few weeks later, one-fourth of the initial cohort entered the terminal stage and developed the following symptoms before death ensued [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/2\" class=\"abstract_t\">2</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>&quot;Stretching spasms&quot;</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><span class=\"nowrap\">Hypotonic/areflexic</span> paresis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Akinetic mutism</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Central pyrexia</p><p/><p>In a report from the United States of three patients with heroin leukoencephalopathy, two were symptomatic, one with dysmetria, abulia, decorticate posturing, and progressive quadriparesis, and a second with a progressive cerebellar syndrome [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3\" class=\"abstract_t\">3</a>]. A third patient, who sought medical help when his friends became ill, was asymptomatic except for signs on examination that suggested mild cerebellar involvement [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3\" class=\"abstract_t\">3</a>].</p><p>Various features of parkinsonism, in some cases reversible, may be seen as early or late manifestations of heroin leukoencephalopathy [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/2,3,6\" class=\"abstract_t\">2,3,6</a>]. These include bradykinesia, tremor, chorea, short festinating steps, masked facies, soft speech, cogwheel rigidity, and loss of postural reflexes.</p><p>Communicating hydrocephalus was described as a complication of heroin inhalation in a single case report [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/9\" class=\"abstract_t\">9</a>].</p><p>The severity of disease probably depends on the amount of heroin inhaled. As an example, a patient who had inhaled 40 to 50 mg of heroin daily for three weeks prior to her hospitalization was unable to perform activities of daily living [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3\" class=\"abstract_t\">3</a>]. Other patients developed milder symptoms with occasional use.</p><p>Once symptoms develop, progression of disease can continue for a few weeks up to six months in the absence of continued exposure [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/2,3,10\" class=\"abstract_t\">2,3,10</a>], a phenomenon called &quot;coasting&quot; [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/11\" class=\"abstract_t\">11</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Neuroimaging</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Brain MRI (<a href=\"image.htm?imageKey=NEURO%2F103815\" class=\"graphic graphic_diagnosticimage graphicRef103815 \">image 1</a>) shows diffuse, symmetrical white matter hyperintensities on T2 and fluid-attenuated inversion recovery (FLAIR) sequences in the cerebellum, posterior cerebrum, and posterior limbs of the internal capsule. There can be additional signal abnormalities in the splenium of the corpus callosum, the corticospinal tracts, the lemniscal pathway in the brainstem, and the hippocampus [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3,12-15\" class=\"abstract_t\">3,12-15</a>]. Increased signal in periventricular white matter may be present on diffusion-weighted images with corresponding low signal on apparent diffusion coefficient (ADC) maps [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/16\" class=\"abstract_t\">16</a>], perhaps due to vacuolization rather than infarction. Most patients demonstrate T2 shine-through with increased ADC signal [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/17\" class=\"abstract_t\">17</a>].</p><p>A posterior-anterior gradient is typically seen in the supratentorial white matter, and the frontal lobes are therefore relatively spared [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3\" class=\"abstract_t\">3</a>]. However, with significant heroin abuse, there may be frontal lobe involvement.</p><p>Magnetic resonance spectroscopy (MRS) abnormalities in three patients with heroin leukoencephalopathy included abnormally elevated lactate suggesting mitochondrial dysfunction in the affected white matter and decreased levels of N-acetyl aspartate and choline in the white matter, gray matter, and cerebellum [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3,15\" class=\"abstract_t\">3,15</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Laboratory</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Electroencephalography in two severely affected patients showed moderate diffuse slowing with excess delta, consistent with a global encephalopathy [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3\" class=\"abstract_t\">3</a>].</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Neuropathology</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pathologic data from autopsy cases as well as brain biopsies reveal spongiform degeneration with relative sparing of subcortical U-fibers, and vacuole formation in oligodendroglia and myelin sheaths visible with electron microscopy. Axons are typically spared, and demyelination is not a prominent feature. The deep white matter is edematous, but inflammation is absent. Mitochondria are also abnormal [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3\" class=\"abstract_t\">3</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of heroin inhalation leukoencephalopathy is clinical and should be suspected in patients with a history of chasing the dragon who present with acute or subacute onset of neurologic abnormalities. These may include one or more of the following features [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/2,3,12\" class=\"abstract_t\">2,3,12</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cerebellar, pyramidal, or extrapyramidal signs</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neurobehavioral changes, including confusion, <span class=\"nowrap\">apathy/abulia,</span> or motor restlessness</p><p/><p>The diagnosis is supported by the characteristic neuroimaging findings. (See <a href=\"#H4\" class=\"local\">'Clinical features'</a> above.)</p><p>Diagnostic uncertainty is increased when the method of heroin abuse or history of exposure is unknown.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Heroin addiction has been associated with a number of neurologic conditions [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/7\" class=\"abstract_t\">7</a>], including brain abscess [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/18\" class=\"abstract_t\">18</a>], transverse myelitis [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/19\" class=\"abstract_t\">19</a>], neuropathy [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/20,21\" class=\"abstract_t\">20,21</a>], and rhabdomyolysis with myoglobinuria [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/22,23\" class=\"abstract_t\">22,23</a>]. However, these disorders are not likely to be confused with leukoencephalopathy.</p><p>In contrast, leukoencephalopathy may occur after global anoxic-ischemic injury or after toxic exposure to a variety of agents, including the following [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/24,25\" class=\"abstract_t\">24,25</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Antineoplastic agents (cranial irradiation, <a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">methotrexate</a>, <a href=\"topic.htm?path=carmustine-drug-information\" class=\"drug drug_general\">carmustine</a>, <a href=\"topic.htm?path=cisplatin-drug-information\" class=\"drug drug_general\">cisplatin</a>, <a href=\"topic.htm?path=cytarabine-drug-information\" class=\"drug drug_general\">cytarabine</a>, <a href=\"topic.htm?path=fluorouracil-drug-information\" class=\"drug drug_general\">fluorouracil</a>, levamisole, <a href=\"topic.htm?path=fludarabine-drug-information\" class=\"drug drug_general\">fludarabine</a>, <a href=\"topic.htm?path=thiotepa-drug-information\" class=\"drug drug_general\">thiotepa</a>, interleukin-2, interferon alfa)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Immunosuppressive drugs (<a href=\"topic.htm?path=cyclosporine-ciclosporin-drug-information\" class=\"drug drug_general\">cyclosporine</a>, <a href=\"topic.htm?path=tacrolimus-drug-information\" class=\"drug drug_general\">tacrolimus</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Antimicrobial agents (amphotericin B, <a href=\"topic.htm?path=hexachlorophene-united-states-not-available-drug-information\" class=\"drug drug_general\">hexachlorophene</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Drugs of abuse (toluene, ethanol, cocaine, 3,4-methylenedioxymethamphetamine, intravenous heroin, inhaled heroin pyrolysate, psilocybin, benzodiazepines)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Environmental toxins (carbon monoxide, arsenic, carbon tetrachloride)</p><p/><p class=\"headingAnchor\" id=\"H10\"><span class=\"h3\">Anoxic-ischemic injury</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Global anoxia or ischemia, which can be precipitated by drug overdose or cardiopulmonary arrest, typically affects the gray matter in the cerebral cortex and various subcortical structures, such as the globus pallidus, with the cerebellum less frequently involved [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/26-28\" class=\"abstract_t\">26-28</a>].</p><p>Cerebral white matter damage may occur with anoxic-ischemic injury, particularly after prolonged hypoxia and hypotension [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/27\" class=\"abstract_t\">27</a>]. The radiologic appearance of white matter damage may be delayed [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/28\" class=\"abstract_t\">28</a>]. Nevertheless, there are reports of early preferential involvement of white matter after anoxic-ischemic injury [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/29,30\" class=\"abstract_t\">29,30</a>]. In addition, drug overdose from intravenous heroin use has been reported as a cause of anoxic-ischemic leukoencephalopathy [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/27\" class=\"abstract_t\">27</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h3\">Drugs of abuse</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Varying degrees of white matter injury may be found in chronic abusers of alcohol and toluene [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/24\" class=\"abstract_t\">24</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chronic alcohol abuse is associated with white matter damage. Alcohol abusers, including those with liver disease and Wernicke encephalopathy, lose a disproportionate amount of subcortical white matter compared with cortical gray matter. Marchiafava-Bignami disease is a rare disorder of demyelination or necrosis of the corpus callosum and adjacent subcortical white matter that occurs predominantly in malnourished alcoholics. (See <a href=\"topic.htm?path=overview-of-the-chronic-neurologic-complications-of-alcohol#H13\" class=\"medical medical_review\">&quot;Overview of the chronic neurologic complications of alcohol&quot;, section on 'Marchiafava-Bignami disease'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chronic toluene abuse from inhalation of vapor in glue (&quot;glue sniffing&quot;), paint, and paint thinner is associated with neurologic impairment, including dementia and selective white matter injury [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/31\" class=\"abstract_t\">31</a>]. Widespread white matter hyperintensity is seen on brain MRI in severely affected patients with toluene leukoencephalopathy. (See <a href=\"topic.htm?path=inhalant-abuse-in-children-and-adolescents\" class=\"medical medical_review\">&quot;Inhalant abuse in children and adolescents&quot;</a>.)</p><p/><p>A case report described a severe diffuse leukoencephalopathy that followed methylenedioxymethamphetamine (MDMA, also called ecstasy) use and respiratory insufficiency [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/32\" class=\"abstract_t\">32</a>]. However, the relative contribution of anoxic-ischemic injury compared with the leukoencephalopathy is unclear.</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is no treatment for heroin leukoencephalopathy. Mortality in the larger published cohorts ranges from 23 to 48 percent [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/2,8\" class=\"abstract_t\">2,8</a>]. Death was primarily due to respiratory failure. (See <a href=\"#H4\" class=\"local\">'Clinical features'</a> above.)</p><p>Empiric antioxidant therapy (with either coenzyme Q10 [300 mg four times a day] alone, or coenzyme Q10 in combination with <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> [2000 mg daily] and <a href=\"topic.htm?path=vitamin-c-ascorbic-acid-drug-information\" class=\"drug drug_general\">vitamin C</a> [2000 mg daily]) was used for two patients, with delayed but gradual improvement in one, and transient improvement correlating with treatment compliance in another [<a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3,33\" class=\"abstract_t\">3,33</a>].</p><p>Given these data, the absence of proven treatment, and the low likelihood of serious side effects, we suggest antioxidant therapy with the combination of coenzyme Q10, <a href=\"topic.htm?path=vitamin-c-ascorbic-acid-drug-information\" class=\"drug drug_general\">vitamin C</a>, and <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> for patients with heroin leukoencephalopathy.</p><p>Patients who survive often require physical and drug rehabilitation.</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>&quot;Chasing the dragon&quot; is a method of heroin vapor inhalation that is distinct from smoking or sniffing heroin and is associated with leukoencephalopathy. (See <a href=\"#H1\" class=\"local\">'Introduction and terminology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The mechanism of neurologic injury related to heroin inhalation is unknown; toxins contained in the heroin pyrolysate may be responsible for the condition. (See <a href=\"#H2\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Initial symptoms of heroin leukoencephalopathy include soft speech, ataxia, motor restlessness, bradyphrenia, and <span class=\"nowrap\">apathy/abulia</span>. Some patients develop progressive disease with later occurrence of pyramidal signs, hyperactive reflexes, pseudobulbar palsy, spastic paresis, tremor, myoclonus, chorea, and athetosis. Severe disease is characterized by fever, akinetic mutism, spasms, hypotonia, areflexia, and death. (See <a href=\"#H4\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Brain MRI (<a href=\"image.htm?imageKey=NEURO%2F103815\" class=\"graphic graphic_diagnosticimage graphicRef103815 \">image 1</a>) shows diffuse, symmetrical white matter hyperintensities on T2 and fluid-attenuated inversion recovery (FLAIR) sequences with a posterior to anterior gradient of involvement; the frontal lobes are therefore relatively spared. (See <a href=\"#H5\" class=\"local\">'Neuroimaging'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neuropathology reveals spongiform degeneration with relative sparing of subcortical U-fibers; demyelination is not a prominent feature. (See <a href=\"#H7\" class=\"local\">'Neuropathology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of heroin inhalation leukoencephalopathy is clinical, and is supported by the characteristic neuroimaging findings. The differential diagnosis includes leukoencephalopathy following global anoxic-ischemic injury or exposure to other drugs of abuse. (See <a href=\"#H8\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Although there is no proven treatment for heroin leukoencephalopathy, we suggest antioxidant therapy (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). The suggested regimen is coenzyme Q10 (300 mg four times a day), <a href=\"topic.htm?path=vitamin-e-drug-information\" class=\"drug drug_general\">vitamin E</a> (2000 mg daily), and <a href=\"topic.htm?path=vitamin-c-ascorbic-acid-drug-information\" class=\"drug drug_general\">vitamin C</a> (2000 mg daily). (See <a href=\"#H12\" class=\"local\">'Treatment'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H103724555\"><span class=\"h1\">ACKNOWLEDGMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge Alan Percy, MD, who contributed to earlier versions of this topic review.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/1\" class=\"nounderline abstract_t\">Strang J, Griffiths P, Gossop M. Heroin smoking by 'chasing the dragon': origins and history. Addiction 1997; 92:673.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/2\" class=\"nounderline abstract_t\">Wolters EC, van Wijngaarden GK, Stam FC, et al. Leucoencephalopathy after inhaling &quot;heroin&quot; pyrolysate. Lancet 1982; 2:1233.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/3\" class=\"nounderline abstract_t\">Kriegstein AR, Shungu DC, Millar WS, et al. Leukoencephalopathy and raised brain lactate from heroin vapor inhalation (&quot;chasing the dragon&quot;). Neurology 1999; 53:1765.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/4\" class=\"nounderline abstract_t\">Keogh CF, Andrews GT, Spacey SD, et al. Neuroimaging features of heroin inhalation toxicity: &quot;chasing the dragon&quot;. AJR Am J Roentgenol 2003; 180:847.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/5\" class=\"nounderline abstract_t\">Squibb RE, Carmichael NG, Tilson HA. Behavioral and neuromorphological effects of triethyl tin bromide in adult rats. Toxicol Appl Pharmacol 1980; 55:188.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/6\" class=\"nounderline abstract_t\">Heales S, Crawley F, Rudge P. Reversible parkinsonism following heroin pyrolysate inhalation is associated with tetrahydrobiopterin deficiency. Mov Disord 2004; 19:1248.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/7\" class=\"nounderline abstract_t\">Hill MD, Cooper PW, Perry JR. Chasing the dragon--neurological toxicity associated with inhalation of heroin vapour: case report. CMAJ 2000; 162:236.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/8\" class=\"nounderline abstract_t\">Buxton JA, Sebastian R, Clearsky L, et al. Chasing the dragon - characterizing cases of leukoencephalopathy associated with heroin inhalation in British Columbia. Harm Reduct J 2011; 8:3.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/9\" class=\"nounderline abstract_t\">Bui DH, Pace J, Manjila S, et al. Heroin inhalation complicated by refractory hydrocephalus: A novel presentation. Neurology 2015; 84:2093.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/10\" class=\"nounderline abstract_t\">Sempere AP, Posada I, Ramo C, Cabello A. Spongiform leucoencephalopathy after inhaling heroin. Lancet 1991; 338:320.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/11\" class=\"nounderline abstract_t\">Berger AR, Schaumburg HH, Schroeder C, et al. Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity. Neurology 1992; 42:1367.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/12\" class=\"nounderline abstract_t\">Long H, Deore K, Hoffman RS, Nelson LS. A fatal case of spongiform leukoencephalopathy linked to &quot;chasing the dragon&quot;. J Toxicol Clin Toxicol 2003; 41:887.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/13\" class=\"nounderline abstract_t\">Weber W, Henkes H, M&ouml;ller P, et al. Toxic spongiform leucoencephalopathy after inhaling heroin vapour. Eur Radiol 1998; 8:749.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/14\" class=\"nounderline abstract_t\">Gupta PK, Krishnan PR, Sudhakar PJ. Hippocampal involvement due to heroin inhalation--&quot;chasing the dragon&quot;. Clin Neurol Neurosurg 2009; 111:278.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/15\" class=\"nounderline abstract_t\">Offiah C, Hall E. Heroin-induced leukoencephalopathy: characterization using MRI, diffusion-weighted imaging, and MR spectroscopy. Clin Radiol 2008; 63:146.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/16\" class=\"nounderline abstract_t\">McKinney AM, Kieffer SA, Paylor RT, et al. Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging. AJR Am J Roentgenol 2009; 193:192.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/17\" class=\"nounderline abstract_t\">Hagel J, Andrews G, Vertinsky T, et al. &quot;Chasing the dragon&quot;--imaging of heroin inhalation leukoencephalopathy. Can Assoc Radiol J 2005; 56:199.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/18\" class=\"nounderline abstract_t\">Hershewe GL, Davis LE, Bicknell JM. Primary cerebellar brain abscess from nocardiosis in a heroin addict. Neurology 1988; 38:1655.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/19\" class=\"nounderline abstract_t\">Richter RW, Rosenberg RN. Transverse myelitis associated with heroin addiction. JAMA 1968; 206:1255.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/20\" class=\"nounderline abstract_t\">Amnueilaph R, Boongird P, Leechawengwongs M, Vejjajiva A. Heroin neuropathy. Lancet 1973; 1:1517.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/21\" class=\"nounderline abstract_t\">Loizou LA, Boddie HG. Polyradiculoneuropathy associated with heroin abuse. J Neurol Neurosurg Psychiatry 1978; 41:855.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/22\" class=\"nounderline abstract_t\">Schreiber SN, Liebowitz MR, Bernstein LH, Srinivasan K. Limb compression and renal impairment (crush syndrome) complicating narcotic overdose. N Engl J Med 1971; 284:368.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/23\" class=\"nounderline abstract_t\">de Gans J, Stam J, van Wijngaarden GK. Rhabdomyolysis and concomitant neurological lesions after intravenous heroin abuse. J Neurol Neurosurg Psychiatry 1985; 48:1057.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/24\" class=\"nounderline abstract_t\">Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. N Engl J Med 2001; 345:425.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/25\" class=\"nounderline abstract_t\">Aljarallah S, Al-Hussain F. Acute fatal posthypoxic leukoencephalopathy following benzodiazepine overdose: a case report and review of the literature. BMC Neurol 2015; 15:69.</a></li><li class=\"breakAll\">Meyer A. Intoxication. In: Greenfield's Neuropathology, Blackwood W, McMenemey WH, Meyer A, et al (Eds), Williams &amp; Wilkins, Baltimore 1967.</li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/27\" class=\"nounderline abstract_t\">Ginsberg MD, Hedley-Whyte ET, Richardson EP Jr. Hypoxic-ischemic leukoencephalopathy in man. Arch Neurol 1976; 33:5.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/28\" class=\"nounderline abstract_t\">Sawada H, Udaka F, Seriu N, et al. MRI demonstration of cortical laminar necrosis and delayed white matter injury in anoxic encephalopathy. Neuroradiology 1990; 32:319.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/29\" class=\"nounderline abstract_t\">Chalela JA, Wolf RL, Maldjian JA, Kasner SE. MRI identification of early white matter injury in anoxic-ischemic encephalopathy. Neurology 2001; 56:481.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/30\" class=\"nounderline abstract_t\">Molloy S, Soh C, Williams TL. Reversible delayed posthypoxic leukoencephalopathy. AJNR Am J Neuroradiol 2006; 27:1763.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/31\" class=\"nounderline abstract_t\">Filley CM, Halliday W, Kleinschmidt-DeMasters BK. The effects of toluene on the central nervous system. J Neuropathol Exp Neurol 2004; 63:1.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/32\" class=\"nounderline abstract_t\">Bertram M, Egelhoff T, Schwarz S, Schwab S. Toxic leukencephalopathy following &quot;ecstasy&quot; ingestion. J Neurol 1999; 246:617.</a></li><li><a href=\"https://www.uptodate.com/contents/leukoencephalopathy-due-to-heroin-inhalation-chasing-the-dragon/abstract/33\" class=\"nounderline abstract_t\">Kriegstein AR, Armitage BA, Kim PY. Heroin inhalation and progressive spongiform leukoencephalopathy. N Engl J Med 1997; 336:589.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 1696 Version 14.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H13\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION AND TERMINOLOGY</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">PATHOGENESIS</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">EPIDEMIOLOGY</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">CLINICAL FEATURES</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">Neuroimaging</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Laboratory</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Neuropathology</a></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">DIAGNOSIS</a><ul><li><a href=\"#H9\" id=\"outline-link-H9\">Differential diagnosis</a><ul><li><a href=\"#H10\" id=\"outline-link-H10\">- Anoxic-ischemic injury</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">- Drugs of abuse</a></li></ul></li></ul></li><li><a href=\"#H12\" id=\"outline-link-H12\">TREATMENT</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#H103724555\" id=\"outline-link-H103724555\">ACKNOWLEDGMENT</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"NEURO/1696|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=NEURO/103815\" class=\"graphic graphic_diagnosticimage\">- MRI of severe heroin-induced leukoencephalopathy</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=inhalant-abuse-in-children-and-adolescents\" class=\"medical medical_review\">Inhalant abuse in children and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-chronic-neurologic-complications-of-alcohol\" class=\"medical medical_review\">Overview of the chronic neurologic complications of alcohol</a></li></ul></div></div>","javascript":null}